Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DIO3 opposite strand upstream RNA (DIO3OS) is a long non-coding RNA located on human chromosome 14, transcribed opposite and overlapping with the DIO3 (deiodinase, iodothyronine, type III) gene. DIO3OS is not translated into protein but is thought to have a regulatory function in the imprinting and monoallelic expression of the DIO3 gene, particularly during fetal development. DIO3OS is expressed in several tissues, including gut, liver, lung, placenta, and yolk sac in mouse, with human orthologous expression expected to be similar[3]. Diseases including thyroid cancer and pancreatic cancer have been associated with DIO3OS, although its direct role in disease is still under investigation[2]. DIO3OS is not considered a therapeutic target as it is not an enzyme, receptor, transporter, or protein-coding gene, but rather functions in gene regulation as a long non-coding RNA[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DIO3 opposite strand upstream RNA (DIO3OS).